Holen Sie sich die Stockscreener-App
26.69
5.41%
1.37
Schlusskurs vom Vortag:
$25.32
Offen:
$25.42
24-Stunden-Volumen:
1.57M
Relative Volume:
0.95
Marktkapitalisierung:
$1.32B
Einnahmen:
$224.45M
Nettoeinkommen (Verlust:
$-95.27M
KGV:
-13.83
EPS:
-1.93
Netto-Cashflow:
$-43.74M
1W Leistung:
-1.49%
1M Leistung:
-2.02%
6M Leistung:
+61.46%
1J Leistung:
-13.03%
1-Tages-Spanne:
$24.95
$26.78
1-Wochen-Bereich:
$23.85
$26.91
52-Wochen-Spanne:
$13.50
$32.00
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Vergleichen Sie STAA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
26.69 | 1.25B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
462.74 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
189.03 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
268.22 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.76 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
279.39 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
Global Cataract Surgery Devices Market to Grow at a CAGR of - GlobeNewswire
STAAR Surgical Q3 2025 preliminary net sales up 6.9% to USD 94.7M - Medical Buyer
Yunqi Capital Issues Letter to Board of Directors of Staar Opposing Alcon Acquisition - MarketScreener
Yunqi Capital reiterates opposition to STAAR Surgical-Alcon merger By Investing.com - Investing.com Canada
Yunqi Capital issues letter to Staar Surgical's board calling for timely convening of special meeting to vote on Alcon transaction - MarketScreener
STAAR Surgical earnings missed by $0.02, revenue topped estimates - Investing.com
Proxy firms and shareholders oppose STAAR Surgical acquisition by Alcon - Investing.com
STAAR Surgical rises premarket after Q3 prelim sales beat - TradingView
STAAR Surgical Topped Estimates, But Analysts Still Hold Back - Finimize
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon - MarketScreener
Broadwood Partners Provides Information to Shareholders of STAAR Surgical - MarketScreener
STAA Reports Growth in Net Sales Fueled by December Shipment - GuruFocus
STAAR Surgical (STAA) Releases Q3 Sales Data Exceeding Expectati - GuruFocus
STAAR Surgical reports preliminary Q3 net sales up 6.9% to $94.7 million - Investing.com
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment - MarketScreener
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 - MarketScreener
What data driven models say about STAAR Surgical Company’s futureWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
STAAR Surgical says no other acqusition proposals other than Alcon - MSN
Broadwood urges STAAR board to proceed with acquisition vote By Investing.com - Investing.com Nigeria
Broadwood urges STAAR board to proceed with acquisition vote - Investing.com
27.5% owner Broadwood urges STAAR Surgical shareholders to vote "AGAINST" Alcon sale; vote Oct 23, 2025 - Stock Titan
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Challenges and Investment Potential - DirectorsTalk Interviews
Can STAAR Surgical Company stock resist market sell offs2025 Market Overview & AI Enhanced Execution Alerts - newser.com
ISS recommendation may toll the bell for STAAR–Alcon deal, validates Broadwood - Investing.com
STAAR Surgical (STAA): A Fresh Look at Valuation After Recent Share Price Pullback - simplywall.st
STAAR Surgical (STAA) Urges Stockholders to Support Alcon Merger - GuruFocus
STAAR disputes Broadwood’s claims about acquisition offers - Investing.com India
STAAR disputes Broadwood’s claims about acquisition offers By Investing.com - Investing.com Nigeria
Independent Poxy Advisory Firms Issues Recommendations to Shareholders of Broadwood Partners - MarketScreener
Midday Stock Roundup: Eledon up 16% on Kidney Presentation - Orange County Business Journal
Staar sale to Alcon eclipsed by shareholder, proxy advisor concerns - BioWorld MedTech
Broadwood Partners All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote AGAINST Sale to Alcon - MarketScreener
ISS recommends Staar shareholders reject Alcon's $1.5 billion offer - Reuters
Alcon's (ALC) Proposed Acquisition Faces Major Opposition - GuruFocus
ISS Recommends Staar Shareholders Vote Against Alcon Merger - Orange County Business Journal
Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale - TipRanks
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon - MarketScreener
Oklahoma City NewsThe Oklahoman - FinancialContent
STAAR Surgical (STAA) Shareholders Advised to Reject Alcon's Acq - GuruFocus
Broadwood urges “AGAINST” vote on Alcon deal as advisors dissent - Stock Titan
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon - Stock Titan
STAAR Surgical Announces Merger with Alcon Amid Legal Challenges - TradingView
Where Does STAAR Surgical Stand After EVO+ Launch and Recent Share Price Swings? - Yahoo
Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal
Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada
Broadwood slams STAAR board over “carelessness” in Alcon sale defense - Investing.com
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders - GlobeNewswire Inc.
STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - MSN
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.77%
1.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):